Shivani, SubhashreeSubhashreeShivaniKao, Cheng-YenCheng-YenKaoAmrita ChattopadhyayChen, Jenn-WeiJenn-WeiChenLIANG-CHUAN LAILin, Wei-HungWei-HungLinTZU-PIN LUHuang, I-HsiuI-HsiuHuangTsai, Mong-HsunMong-HsunTsaiTeng, Ching-HaoChing-HaoTengWu, Jiunn-JongJiunn-JongWuHsieh, Yi-HsienYi-HsienHsiehWang, Ming-ChengMing-ChengWangERIC YAO-YU CHUANG2023-01-172023-01-1720222235-2988https://www.scopus.com/inward/record.uri?eid=2-s2.0-85130054271&doi=10.3389%2ffcimb.2022.726256&partnerID=40&md5=1e5b88f448713034cae043054f725adeGut microbiota have been targeted by alternative therapies for non-communicable diseases. We examined the gut microbiota of a healthy Taiwanese population, identified various bacterial drivers in different demographics, and compared them with dialysis patients to associate kidney disease progression with changes in gut microbiota.enTaiwan; chronic kidney disease; dysbiosis; gut microbiota; hemodialysis; peritoneal dialysis; uremic toxinUremic Toxin-Producing Bacteroides Species Prevail in the Gut Microbiota of Taiwanese CKD Patients: An Analysis Using the New Taiwan Microbiome Baselinejournal article10.3389/fcimb.2022.726256355581022-s2.0-85130054271WOS:000805947600001https://api.elsevier.com/content/abstract/scopus_id/85130054271